PALYNOX
LIVE

Serial Number

79336509

Owner

Monsieur Christian Strunden

Attorney

Miriam D. Trudell

Filing Date

Oct 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PALYNOX Trademark

Serial Number: 79336509 • Registration: 7451810

PALYNOX is a trademark filed by Monsieur Christian Strunden on October 19, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Monsieur Christian Strunden

Rue Hirzbodenpark 18

Entity Type: 01

Trademark Details

Filing Date

October 19, 2021

Registration Date

July 23, 2024

Published for Opposition

March 7, 2023

Goods & Services

Health care for human beings, including dietetic and medical services; veterinary services; medical examination services; provision of information relating to dietary and nutritional supplements; consultancy in the pharmaceutical and healthcare services field; advice and information relating to the aforesaid services; advisory services relating to health care; hygienic and beauty care; [ the above-mentioned services are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid services are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *

Pharmaceutical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; phytopharmaceutical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; dietetic and homeopathic products for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; medical preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; veterinary preparations for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression excluding gases for medical use; food and dietary supplements for humans and animals; dietetic food adapted for medical or veterinary use; food supplements consisting of vitamins; food supplements for pharmaceutical use; food supplements for animals; vitamin and mineral food supplements; pharmaceutical for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression sold on prescription or over the counter; veterinary preparations for pets for the treatment of allergies sold on prescription or over the counter; food supplements for pharmaceutical and veterinary use; natural food supplements for allergy treatment; chemical preparations for medical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; chemical preparations for pharmaceutical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; medicinal preparations, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; plant preparations for medical use, namely, for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; [ the above-mentioned goods are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid goods are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *

Scientific and technological services, namely, research in the fields of chemistry, biology and pharmacy; industrial research in the field of pharmaceutical preparations and food supplements for the treatment of allergies, ocular disorders or diseases, prostate disorders or diseases and depression; industrial design services; quality control of goods and services in the field of pharmaceutical preparations; pharmaceutical research and development services; pharmaceutical research services; laboratory research services in the field of pharmaceuticals; [ the above-mentioned services are not intented to be manufactured, commercialised and generally used in the treatment of genetic diseases and disorders and enzyme therapy ] * the aforesaid services are not intended to be manufactured, marketed and generally used in the treatment of genetic disorders and diseases and for enzyme therapy *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 23, 2026 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 6, 2025 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 NURC
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 25, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 8, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 8, 2025 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 6, 2025 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 6, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 6, 2025 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 15, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 15, 2024 REAP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Jun 14, 2024 TMBN
OPPOSITION TERMINATED NO. 999999
Jun 14, 2024 OP.T
OPPOSITION DISMISSED NO. 999999
Jun 14, 2024 OP.D
LIMITATION OF GOODS RECEIVED FROM IB
Apr 28, 2024 LIMG
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 9, 2024 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Feb 4, 2024 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 16, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 30, 2023 OPNR
REFUSAL PROCESSED BY IB
Aug 1, 2023 RFNT
OPPOSITION INSTITUTED NO. 999999
Jul 11, 2023 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Jul 4, 2023 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jul 4, 2023 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 5, 2023 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 7, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Mar 6, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 15, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 15, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2022 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 5, 2022 RFCS
REFUSAL PROCESSED BY MPU
Aug 4, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 26, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2022 REPR